Connection

James Ballenger to Antidepressive Agents, Second-Generation

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Antidepressive Agents, Second-Generation.
James Ballenger
Connection Strength
0.170
Antidepressive Agents, Second-Generation
  1. Clinical evaluation of venlafaxine. J Clin Psychopharmacol. 1996 Jun; 16(3 Suppl 2):29S-35S; discussion 35S-36S.
    View in: PubMed
    Score: 0.129
  2. Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.